In-vitro Diagnostics Market (IVD Market) by Product & Solution (Consumables, Systems, Software & Services), Technology (ELISA, Rapid Tests, PCR, Microbiology), Application (Infectious Diseases, Oncology), End User (Hospitals, Diagnostic Laboratories) – Forecast to 2027
In-vitro Diagnostics Market by Product & Solution (Consumables, Systems, Software & Services), Technology (ELISA, Rapid Tests, PCR, Microbiology), Application (Infectious Diseases, Oncology), End User (Hospitals, Diagnostic Laboratories)—Forecast to 2027
The in-vitro diagnostics market is expected to register a CAGR of 7.0% from 2020 to 2027 to reach $118.50 billion by 2027.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report showcases the key industry drivers, restraints, challenges, and opportunities. The growth of the in-vitro diagnostics market is mainly attributed to the increasing global prevalence of acute and chronic infectious diseases associated with the rising geriatric population, growing awareness regarding the importance of early disease diagnosis, a shift in the focus from centralized to point-of-care testing, and the emergence of the COVID-19 pandemic. Moreover, emerging economies, the development of condition-specific markers and tests, and advances in genomics and proteomics offer significant growth opportunities for the players operating in this market.
In 2020, based on the type of immunoassay diagnostic technologies, the enzyme-linked immunosorbent assay (ELISA) segment is estimated to account for the largest share of the IVD immunoassay market. The continuous development of new biomarkers and the cost-benefits and growing adoption of automated platforms for ELISA are expected to increase this technology's adoption. This technology’s efficiency, convenience, and accuracy are also expected to propel the segment's growth.
In 2020, based on product & solution, the consumables segment is estimated to account for the largest share of the IVD market due to the frequent use of assays & kits in the detection of various chronic diseases, the large-scale availability of a diverse range of reagents & consumables for the diagnosis of various diseases, and increase in the volume of testing for infectious disease. In addition to this, the increase in demand for COVID-19 testing products and the cost-effectiveness of these products are factors that are expected to accelerate the growth of the consumables segment in the upcoming years.
Based on end user, the hospitals & clinics segment is estimated to register the fastest growth during the forecast period, 2020–2027. Factors contributing to this segment's growth include the rise in hospital expenditures, the growing adoption of technologically advanced diagnostic platforms among hospitals, increasing preference for in-house diagnostic facilities, and growing patient volumes leading to increased testing in hospitals.
An in-depth analysis of the in-vitro diagnostics market's geographical scenario provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major country-level markets in each region. In 2020, North America was estimated to account for the largest share of the IVD market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The key players operating in the in-vitro diagnostics market are Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioM?rieux S.A. (France), Thermo Fisher Scientific (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Ortho Clinical Diagnostics (U.S.), Siemens Healthcare GmbH (Germany), Sysmex Corporation (Japan), and Qiagen N.V. (Netherlands), among others.
Scope of the Report:
In-vitro Diagnostics Market, by Product & Solution
In-vitro Diagnostics Market, by Application
In-vitro Diagnostics Market, by End User
In-vitro Diagnostics Market, by Geography
The in-vitro diagnostics market is expected to register a CAGR of 7.0% from 2020 to 2027 to reach $118.50 billion by 2027.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report showcases the key industry drivers, restraints, challenges, and opportunities. The growth of the in-vitro diagnostics market is mainly attributed to the increasing global prevalence of acute and chronic infectious diseases associated with the rising geriatric population, growing awareness regarding the importance of early disease diagnosis, a shift in the focus from centralized to point-of-care testing, and the emergence of the COVID-19 pandemic. Moreover, emerging economies, the development of condition-specific markers and tests, and advances in genomics and proteomics offer significant growth opportunities for the players operating in this market.
In 2020, based on the type of immunoassay diagnostic technologies, the enzyme-linked immunosorbent assay (ELISA) segment is estimated to account for the largest share of the IVD immunoassay market. The continuous development of new biomarkers and the cost-benefits and growing adoption of automated platforms for ELISA are expected to increase this technology's adoption. This technology’s efficiency, convenience, and accuracy are also expected to propel the segment's growth.
In 2020, based on product & solution, the consumables segment is estimated to account for the largest share of the IVD market due to the frequent use of assays & kits in the detection of various chronic diseases, the large-scale availability of a diverse range of reagents & consumables for the diagnosis of various diseases, and increase in the volume of testing for infectious disease. In addition to this, the increase in demand for COVID-19 testing products and the cost-effectiveness of these products are factors that are expected to accelerate the growth of the consumables segment in the upcoming years.
Based on end user, the hospitals & clinics segment is estimated to register the fastest growth during the forecast period, 2020–2027. Factors contributing to this segment's growth include the rise in hospital expenditures, the growing adoption of technologically advanced diagnostic platforms among hospitals, increasing preference for in-house diagnostic facilities, and growing patient volumes leading to increased testing in hospitals.
An in-depth analysis of the in-vitro diagnostics market's geographical scenario provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major country-level markets in each region. In 2020, North America was estimated to account for the largest share of the IVD market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The key players operating in the in-vitro diagnostics market are Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioM?rieux S.A. (France), Thermo Fisher Scientific (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Ortho Clinical Diagnostics (U.S.), Siemens Healthcare GmbH (Germany), Sysmex Corporation (Japan), and Qiagen N.V. (Netherlands), among others.
Scope of the Report:
In-vitro Diagnostics Market, by Product & Solution
- Consumables
- Systems
- Software & Services
- Immunoassay/Immunochemistry
- Enzyme-linked Immunosorbent Assay (ELISA)
- Radioimmunoassay
- Rapid Tests
- Western Blotting
- Enzyme-linked Immunospot Assays
- Biochemistry/Clinical Chemistry
- Molecular Diagnostics
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology
- Microarray
- Hybridization
- DNA Sequencing & Next-generation Sequencing
- Microbiology
- Hematology
- Coagulation/Hemostasis
- Urinalysis
- Other Technologies*
In-vitro Diagnostics Market, by Application
- Infectious Diseases
- Oncology
- Endocrinology
- Diabetes
- Cardiology
- Nephrology
- Other Applications*
In-vitro Diagnostics Market, by End User
- Diagnostic Reference Laboratories
- Hospitals & Clinics
- Home Healthcare
- Other End Users*
In-vitro Diagnostics Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- Latin America
- Middle East & Africa
1. INTRODUCTION
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Introduction
4.2. Drivers
4.2.1. Rising Prevalence of Acute and Chronic Infectious Diseases
4.2.2. Increase in Funding for Research Activities
4.2.3. Growing Awareness for Early Disease Diagnosis
4.2.4. Shift in the Focus from Centralized to Point-of-Care Testing
4.2.5. The Impact of COVID-19
4.3. Restraints
4.3.1. Technical Requirements and Regulatory Process for High or Moderate-Complexity Tests
4.4. Opportunities
4.4.1. Development of Condition-Specific Markers and Tests
4.4.2. Significant Opportunities in Emerging Markets
4.4.3. Advances in Genomics and Proteomics
4.5. Challenges
4.5.1. Unfavorable Reimbursement Scenario
4.5.2. Lack of Awareness of Specific Symptoms and Diagnosis of Emerging Infections
5. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SOLUTION
5.1. Introduction
5.2. Consumables
5.3. Systems
5.4. Software & Services
6. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Immunoassay/Immunochemistry
6.2.1 Enzyme-Linked Immunosorbent Assays (ELISA)
6.2.2 Radioimmunoassays
6.2.3. Rapid Tests
6.2.4. Western Blotting
6.2.5. Enzyme-Linked Immunospot Assays
6.3. Biochemistry/Clinical Chemistry
6.4. Molecular Diagnostics
6.4.1. Polymerase Chain Reaction (PCR)
6.4.2. Isothermal Nucleic Acid Amplification Technology
6.4.3. Microarray
6.4.4. Hybridization
6.4.5. DNA Sequencing & Next-generation Sequencing
6.5. Microbiology
6.6. Hematology
6.7. Coagulation/Hemostasis
6.8. Urinalysis
6.9. Other Technologies
7. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION
7.1. Infectious Diseases
7.2. Oncology
7.3. Endocrinology
7.4. Diabetes
7.5. Cardiology
7.6. Nephrology
7.7. Other Applications
8. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER
8.1. Diagnostic Reference Laboratories
8.2. Hospitals & Clinics
8.3. Home Healthcare
8.4. Other End Users
9. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East & Africa
10. COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2019)
11. COMPANY PROFILES
11.1. Becton, Dickinson and Company
11.1.1 Business Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. Strategic Developments
11.2. Danaher Corporation
11.2.1 Business Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.3. Thermo Fisher Scientific Inc.
11.3.1 Business Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. Strategic Developments
11.4. Abbott Laboratories
11.4.1 Business Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.5. Ortho Clinical Diagnostics
11.5.1 Business Overview
11.5.2. Product Portfolio
11.5.3. Strategic Developments
11.6. Siemens Healthcare Gmbh
11.6.1 Business Overview
11.6.2. Financial Overview
11.6.3. Product Portfolio
11.6.4. Strategic Developments
11.7. Sysmex Corporation
11.7.1 Business Overview
11.7.2. Financial Overview
11.7.3. Product Portfolio
11.7.4. Strategic Developments
11.8. Bio-Rad Laboratories, Inc.
11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.8.4. Strategic Developments
11.9. biom?rieux SA
11.9.1. Business Overview
11.9.2. Financial Overview
11.9.3. Product Portfolio
11.9.4. Strategic Developments
11.10. Diasorin S.P.A.
11.10.1. Business Overview
11.10.2. Financial Overview
11.10.3. Product Portfolio
11.10.4. Strategic Developments
11.11. QIAGEN N.V.
11.11.1 Business Overview
11.11.2. Financial Overview
11.11.3. Product Portfolio
11.11.4. Strategic Developments
11.12. Agilent Technologies, Inc.
11.12.1 Business Overview
11.12.2. Financial Overview
11.12.3. Product Portfolio
11.12.4. Strategic Developments
11.13. F. Hoffmann-La Roche Ltd.
11.13.1. Business Overview
11.13.2. Financial Overview
11.13.3. Product Portfolio
11.13.4. Strategic Developments
12. APPENDIX
12.1. Questionnaire
12.2. Available Customization
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Introduction
4.2. Drivers
4.2.1. Rising Prevalence of Acute and Chronic Infectious Diseases
4.2.2. Increase in Funding for Research Activities
4.2.3. Growing Awareness for Early Disease Diagnosis
4.2.4. Shift in the Focus from Centralized to Point-of-Care Testing
4.2.5. The Impact of COVID-19
4.3. Restraints
4.3.1. Technical Requirements and Regulatory Process for High or Moderate-Complexity Tests
4.4. Opportunities
4.4.1. Development of Condition-Specific Markers and Tests
4.4.2. Significant Opportunities in Emerging Markets
4.4.3. Advances in Genomics and Proteomics
4.5. Challenges
4.5.1. Unfavorable Reimbursement Scenario
4.5.2. Lack of Awareness of Specific Symptoms and Diagnosis of Emerging Infections
5. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SOLUTION
5.1. Introduction
5.2. Consumables
5.3. Systems
5.4. Software & Services
6. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Immunoassay/Immunochemistry
6.2.1 Enzyme-Linked Immunosorbent Assays (ELISA)
6.2.2 Radioimmunoassays
6.2.3. Rapid Tests
6.2.4. Western Blotting
6.2.5. Enzyme-Linked Immunospot Assays
6.3. Biochemistry/Clinical Chemistry
6.4. Molecular Diagnostics
6.4.1. Polymerase Chain Reaction (PCR)
6.4.2. Isothermal Nucleic Acid Amplification Technology
6.4.3. Microarray
6.4.4. Hybridization
6.4.5. DNA Sequencing & Next-generation Sequencing
6.5. Microbiology
6.6. Hematology
6.7. Coagulation/Hemostasis
6.8. Urinalysis
6.9. Other Technologies
7. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION
7.1. Infectious Diseases
7.2. Oncology
7.3. Endocrinology
7.4. Diabetes
7.5. Cardiology
7.6. Nephrology
7.7. Other Applications
8. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER
8.1. Diagnostic Reference Laboratories
8.2. Hospitals & Clinics
8.3. Home Healthcare
8.4. Other End Users
9. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East & Africa
10. COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2019)
11. COMPANY PROFILES
11.1. Becton, Dickinson and Company
11.1.1 Business Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. Strategic Developments
11.2. Danaher Corporation
11.2.1 Business Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.3. Thermo Fisher Scientific Inc.
11.3.1 Business Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. Strategic Developments
11.4. Abbott Laboratories
11.4.1 Business Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.5. Ortho Clinical Diagnostics
11.5.1 Business Overview
11.5.2. Product Portfolio
11.5.3. Strategic Developments
11.6. Siemens Healthcare Gmbh
11.6.1 Business Overview
11.6.2. Financial Overview
11.6.3. Product Portfolio
11.6.4. Strategic Developments
11.7. Sysmex Corporation
11.7.1 Business Overview
11.7.2. Financial Overview
11.7.3. Product Portfolio
11.7.4. Strategic Developments
11.8. Bio-Rad Laboratories, Inc.
11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.8.4. Strategic Developments
11.9. biom?rieux SA
11.9.1. Business Overview
11.9.2. Financial Overview
11.9.3. Product Portfolio
11.9.4. Strategic Developments
11.10. Diasorin S.P.A.
11.10.1. Business Overview
11.10.2. Financial Overview
11.10.3. Product Portfolio
11.10.4. Strategic Developments
11.11. QIAGEN N.V.
11.11.1 Business Overview
11.11.2. Financial Overview
11.11.3. Product Portfolio
11.11.4. Strategic Developments
11.12. Agilent Technologies, Inc.
11.12.1 Business Overview
11.12.2. Financial Overview
11.12.3. Product Portfolio
11.12.4. Strategic Developments
11.13. F. Hoffmann-La Roche Ltd.
11.13.1. Business Overview
11.13.2. Financial Overview
11.13.3. Product Portfolio
11.13.4. Strategic Developments
12. APPENDIX
12.1. Questionnaire
12.2. Available Customization
LIST OF TABLES
Table 1 Global IVD Market Drivers: Impact Analysis (2020–2027)
Table 2 Global IVD Market Restraints: Impact Analysis (2020–2027)
Table 3 Global In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 4 Global IVD Consumables Market Size, by Country/Region, 2018–2027 (USD Million)
Table 5 Global IVD Systems Market Size, by Country/Region, 2018–2027 (USD Million)
Table 6 Global IVD Software & Services Market Size, by Country/Region, 2018–2027 (USD Million)
Table 7 Global In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 8 Global Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 9 Global Immunoassays Market Size, by Country/Region, 2018–2027 (USD Million)
Table 10 Global Enzyme-Linked Immunosorbent Assays Market Size, by Country/Region, 2018–2027 (USD Million)
Table 11 Global Radioimmunoassays Market Size, by Country/Region, 2018–2027 (USD Million)
Table 12 Global Rapid Tests Market Size, by Country/Region, 2018–2027 (USD Million)
Table 13 Global Western Blotting Market Size, by Country/Region, 2018–2027 (USD Million)
Table 14 Global Enzyme-linked Immunospot Assays Market Size, by Country/Region, 2018–2027 (USD Million)
Table 15 Global Clinical Chemistry Market Size, by Country/Region, 2018–2027 (USD Million)
Table 16 Global Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 17 Global Polymerase Chain Reaction Market Size, by Country/Region, 2018–2027 (USD Million)
Table 18 Global Isothermal Nucleic Acid Amplification Technology Market Size, by Country/Region, 2018–2027 (USD Million)
Table 19 Global Microarray Market Size, by Country/Region, 2018–2027 (USD Million)
Table 20 Global Hybridization Market Size, by Country/Region, 2018–2027 (USD Million)
Table 21 Global DNA Sequencing & Next-generation Sequencing Market Size, by Country/Region, 2018–2027 (USD Million)
Table 22 Global Microbiology Market Size, by Country/Region, 2018–2027 (USD Million)
Table 23 Global Hematology Market Size, by Country/Region, 2018–2027 (USD Million)
Table 24 Global Coagulation and Hemostasis Market Size, by Country/Region, 2018–2027 (USD Million)
Table 25 Global Urinalysis Market Size, by Country/Region, 2018–2027 (USD Million)
Table 26 Global Other IVD Technologies Market Size, by Country/Region, 2018–2027 (USD Million)
Table 27 Global IVD Market Size for Infectious Diseases, by Country/Region, 2018–2027 (USD Million)
Table 28 Global IVD Market Size for Oncology, by Country/Region, 2018–2027 (USD Million)
Table 29 Global IVD Market Size for Endocrinology, by Country/Region, 2018–2027 (USD Million)
Table 30 Global IVD Market Size for Diabetes, by Country/Region, 2018–2027 (USD Million)
Table 31 Global IVD Market Size for Cardiology, by Country/Region, 2018–2027 (USD Million)
Table 32 Global IVD Market Size for Nephrology, by Country/Region, 2018–2027 (USD Million)
Table 33 Global IVD Market Size for Other Applications, by Country/Region, 2018–2027 (USD Million)
Table 34 Global IVD Market Size for Hospitals & Clinics, by Country/Region, 2018–2027 (USD Million)
Table 35 Global IVD Market Size for Diagnostic Reference Laboratories, by Country/Region, 2018–2027 (USD Million)
Table 36 Global IVD Market Size for Home Healthcare, by Country/Region, 2018–2027 (USD Million)
Table 37 Global IVD Market Size for Other End Users, by Country/Region, 2018–2027 (USD Million)
Table 38 Global In-vitro Diagnostics Market Size, by Country/Region, 2018–2027 (USD Million)
Table 39 North America: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 40 North America: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 41 North America: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 42 North America: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 43 North America: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 44 North America: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 45 North America: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 46 U.S.: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 47 U.S.: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 48 U.S.: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 49 U.S.: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 50 U.S.: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 51 U.S.: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 52 Canada: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 53 Canada: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 54 Canada: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 55 Canada: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 56 Canada: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 57 Canada: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 58 Europe: In-vitro Diagnostics Market Size, by Country, 2018–2027 (USD Million)
Table 59 Europe: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 60 Europe: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 61 Europe: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 62 Europe: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 63 Europe: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 64 Europe: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 65 Germany: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 66 Germany: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 67 Germany: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 68 Germany: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 69 Germany: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 70 Germany: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 71 U.K.: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 72 U.K.: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 73 U.K.: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 74 U.K.: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 75 U.K.: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 76 U.K.: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 77 France: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 78 France: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 79 France: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 80 France: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 81 France: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 82 France: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 83 Italy: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 84 Italy: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 85 Italy: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 86 Italy: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 87 Italy: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 88 Italy: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 89 Spain: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 90 Spain: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 91 Spain: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 92 Spain: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 93 Spain: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 94 Spain: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 95 RoE: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 96 RoE: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 97 RoE: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 98 RoE: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 99 RoE: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 100 RoE: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 101 Asia-Pacific: In-vitro Diagnostics Market Size, by Country, 2018–2027 (USD Million)
Table 102 Asia-Pacific: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 103 Asia-Pacific: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 104 Asia-Pacific: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 105 Asia-Pacific: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 106 Asia-Pacific: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 107 Asia-Pacific: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 108 China: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 109 China: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 110 China: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 111 China: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 112 China: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 113 China: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 114 Japan: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 115 Japan: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 116 Japan: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 117 Japan: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 118 Japan: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 119 Japan: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 120 India: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 121 India: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 122 India: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 123 India: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 124 India: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 125 India: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 126 Roapac: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 127 RoAPAC: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 128 RoAPAC: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 129 RoAPAC: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 130 RoAPAC: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 131 RoAPAC: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 132 Latin America: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 133 Latin America: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 134 Latin America: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 135 Latin America: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 136 Latin America: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 137 Latin America: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 138 Middle East & Africa: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 ( USD Million)
Table 139 Middle East & Africa: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 140 Middle East & Africa: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 141 Middle East & Africa: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 142 Middle East & Africa: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 143 Middle East & Africa: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 144 Recent Developments, by Company, 2017–2020
Table 1 Global IVD Market Drivers: Impact Analysis (2020–2027)
Table 2 Global IVD Market Restraints: Impact Analysis (2020–2027)
Table 3 Global In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 4 Global IVD Consumables Market Size, by Country/Region, 2018–2027 (USD Million)
Table 5 Global IVD Systems Market Size, by Country/Region, 2018–2027 (USD Million)
Table 6 Global IVD Software & Services Market Size, by Country/Region, 2018–2027 (USD Million)
Table 7 Global In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 8 Global Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 9 Global Immunoassays Market Size, by Country/Region, 2018–2027 (USD Million)
Table 10 Global Enzyme-Linked Immunosorbent Assays Market Size, by Country/Region, 2018–2027 (USD Million)
Table 11 Global Radioimmunoassays Market Size, by Country/Region, 2018–2027 (USD Million)
Table 12 Global Rapid Tests Market Size, by Country/Region, 2018–2027 (USD Million)
Table 13 Global Western Blotting Market Size, by Country/Region, 2018–2027 (USD Million)
Table 14 Global Enzyme-linked Immunospot Assays Market Size, by Country/Region, 2018–2027 (USD Million)
Table 15 Global Clinical Chemistry Market Size, by Country/Region, 2018–2027 (USD Million)
Table 16 Global Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 17 Global Polymerase Chain Reaction Market Size, by Country/Region, 2018–2027 (USD Million)
Table 18 Global Isothermal Nucleic Acid Amplification Technology Market Size, by Country/Region, 2018–2027 (USD Million)
Table 19 Global Microarray Market Size, by Country/Region, 2018–2027 (USD Million)
Table 20 Global Hybridization Market Size, by Country/Region, 2018–2027 (USD Million)
Table 21 Global DNA Sequencing & Next-generation Sequencing Market Size, by Country/Region, 2018–2027 (USD Million)
Table 22 Global Microbiology Market Size, by Country/Region, 2018–2027 (USD Million)
Table 23 Global Hematology Market Size, by Country/Region, 2018–2027 (USD Million)
Table 24 Global Coagulation and Hemostasis Market Size, by Country/Region, 2018–2027 (USD Million)
Table 25 Global Urinalysis Market Size, by Country/Region, 2018–2027 (USD Million)
Table 26 Global Other IVD Technologies Market Size, by Country/Region, 2018–2027 (USD Million)
Table 27 Global IVD Market Size for Infectious Diseases, by Country/Region, 2018–2027 (USD Million)
Table 28 Global IVD Market Size for Oncology, by Country/Region, 2018–2027 (USD Million)
Table 29 Global IVD Market Size for Endocrinology, by Country/Region, 2018–2027 (USD Million)
Table 30 Global IVD Market Size for Diabetes, by Country/Region, 2018–2027 (USD Million)
Table 31 Global IVD Market Size for Cardiology, by Country/Region, 2018–2027 (USD Million)
Table 32 Global IVD Market Size for Nephrology, by Country/Region, 2018–2027 (USD Million)
Table 33 Global IVD Market Size for Other Applications, by Country/Region, 2018–2027 (USD Million)
Table 34 Global IVD Market Size for Hospitals & Clinics, by Country/Region, 2018–2027 (USD Million)
Table 35 Global IVD Market Size for Diagnostic Reference Laboratories, by Country/Region, 2018–2027 (USD Million)
Table 36 Global IVD Market Size for Home Healthcare, by Country/Region, 2018–2027 (USD Million)
Table 37 Global IVD Market Size for Other End Users, by Country/Region, 2018–2027 (USD Million)
Table 38 Global In-vitro Diagnostics Market Size, by Country/Region, 2018–2027 (USD Million)
Table 39 North America: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 40 North America: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 41 North America: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 42 North America: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 43 North America: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 44 North America: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 45 North America: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 46 U.S.: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 47 U.S.: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 48 U.S.: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 49 U.S.: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 50 U.S.: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 51 U.S.: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 52 Canada: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 53 Canada: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 54 Canada: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 55 Canada: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 56 Canada: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 57 Canada: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 58 Europe: In-vitro Diagnostics Market Size, by Country, 2018–2027 (USD Million)
Table 59 Europe: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 60 Europe: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 61 Europe: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 62 Europe: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 63 Europe: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 64 Europe: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 65 Germany: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 66 Germany: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 67 Germany: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 68 Germany: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 69 Germany: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 70 Germany: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 71 U.K.: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 72 U.K.: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 73 U.K.: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 74 U.K.: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 75 U.K.: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 76 U.K.: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 77 France: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 78 France: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 79 France: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 80 France: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 81 France: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 82 France: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 83 Italy: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 84 Italy: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 85 Italy: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 86 Italy: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 87 Italy: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 88 Italy: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 89 Spain: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 90 Spain: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 91 Spain: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 92 Spain: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 93 Spain: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 94 Spain: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 95 RoE: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 96 RoE: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 97 RoE: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 98 RoE: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 99 RoE: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 100 RoE: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 101 Asia-Pacific: In-vitro Diagnostics Market Size, by Country, 2018–2027 (USD Million)
Table 102 Asia-Pacific: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 103 Asia-Pacific: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 104 Asia-Pacific: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 105 Asia-Pacific: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 106 Asia-Pacific: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 107 Asia-Pacific: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 108 China: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 109 China: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 110 China: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 111 China: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 112 China: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 113 China: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 114 Japan: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 115 Japan: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 116 Japan: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 117 Japan: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 118 Japan: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 119 Japan: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 120 India: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 121 India: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 122 India: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 123 India: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 124 India: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 125 India: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 126 Roapac: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 127 RoAPAC: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 128 RoAPAC: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 129 RoAPAC: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 130 RoAPAC: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 131 RoAPAC: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 132 Latin America: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 (USD Million)
Table 133 Latin America: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 134 Latin America: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 135 Latin America: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 136 Latin America: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 137 Latin America: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 138 Middle East & Africa: In-vitro Diagnostics Market Size, by Product & Solution, 2018–2027 ( USD Million)
Table 139 Middle East & Africa: In-vitro Diagnostics Market Size, by Technology, 2018–2027 (USD Million)
Table 140 Middle East & Africa: Immunoassays Market Size, by Type, 2018–2027 (USD Million)
Table 141 Middle East & Africa: Molecular Diagnostics Market Size, by Type, 2018–2027 (USD Million)
Table 142 Middle East & Africa: In-vitro Diagnostics Market Size, by Application, 2018–2027 (USD Million)
Table 143 Middle East & Africa: In-vitro Diagnostics Market Size, by End User, 2018–2027 (USD Million)
Table 144 Recent Developments, by Company, 2017–2020
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Methodology
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global In-vitro Diagnostics Market Size, by Product & Solution, 2020 Vs. 2027 (USD Million)
Figure 8 Global In-vitro Diagnostics Market Size, by Technology, 2020 Vs. 2027 (USD Million)
Figure 9 Global In-vitro Diagnostics Market Size, by Application, 2020 Vs. 2027 (USD Million)
Figure 10 Hospital & Clinics Are Expected to Dominate the IVD Market, by End User (2020–2027)
Figure 11 IVD Market Size, by Region
Figure 12 Market Dynamics
Figure 13 Global In-vitro Diagnostics Market Size, by Product & Solution, 2020–2027 (USD Million)
Figure 14 Global In-vitro Diagnostics Market Size, by Technology, 2020–2027 (USD Million)
Figure 15 Global In-vitro Diagnostics Market Size, by Application, 2020–2027 (USD Million)
Figure 16 Global In-vitro Diagnostics Market Size, by End User, 2020–2027 (USD Million)
Figure 17 Global In-vitro Diagnostics Market Size, by Geography, 2020–2027 (USD Million)
Figure 18 North America: In-vitro Diagnostics Market Snapshot
Figure 19 Europe: In-vitro Diagnostics Market Snapshot
Figure 20 Asia-Pacific: In-vitro Diagnostics Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players, 2017–2020
Figure 22 Global In-vitro Diagnostics Market: Competitive Benchmarking
Figure 23 Market Share Analysis: IVD Industry, 2019
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Methodology
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global In-vitro Diagnostics Market Size, by Product & Solution, 2020 Vs. 2027 (USD Million)
Figure 8 Global In-vitro Diagnostics Market Size, by Technology, 2020 Vs. 2027 (USD Million)
Figure 9 Global In-vitro Diagnostics Market Size, by Application, 2020 Vs. 2027 (USD Million)
Figure 10 Hospital & Clinics Are Expected to Dominate the IVD Market, by End User (2020–2027)
Figure 11 IVD Market Size, by Region
Figure 12 Market Dynamics
Figure 13 Global In-vitro Diagnostics Market Size, by Product & Solution, 2020–2027 (USD Million)
Figure 14 Global In-vitro Diagnostics Market Size, by Technology, 2020–2027 (USD Million)
Figure 15 Global In-vitro Diagnostics Market Size, by Application, 2020–2027 (USD Million)
Figure 16 Global In-vitro Diagnostics Market Size, by End User, 2020–2027 (USD Million)
Figure 17 Global In-vitro Diagnostics Market Size, by Geography, 2020–2027 (USD Million)
Figure 18 North America: In-vitro Diagnostics Market Snapshot
Figure 19 Europe: In-vitro Diagnostics Market Snapshot
Figure 20 Asia-Pacific: In-vitro Diagnostics Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players, 2017–2020
Figure 22 Global In-vitro Diagnostics Market: Competitive Benchmarking
Figure 23 Market Share Analysis: IVD Industry, 2019
